Health

STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 07/10/2026, 21:21:26 UTC.

Briefings

The Pharmaceutical Research and Manufacturers of America filed a lawsuit against the Trump administration, challenging a pilot Medicare program called GLOBE that mandates drug prices to match those in other countries. The lawsuit asserts that this 'most-favored nation' approach exceeds Medicare's statutory authority. The program is expected to have minimal impact because the administration exempted nearly all pharmaceutical companies from the mandate in exchange for voluntary agreements to charge Medicaid MFN prices.

Key points

• The Pharmaceutical Research and Manufacturers of America filed a complaint in the U.S. District Court for the District of Columbia challenging the GLOBE pilot program.
• The GLOBE program ties Medicare drug prices to those in peer countries, which the industry claims exceeds statutory authority.

Context and limitations

The evidence covers a specific lawsuit filed on October 7, 2026, regarding the GLOBE pilot program. Coverage is limited to the initial lawsuit details and does not include outcomes, settlement status, or long-term impact assessments.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 08/10/2026, 03:19:10 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiadyzez4pwmzj5y4zu6cly7lev7p7wobmhq4ukacx2x6kxvsbi4pq